In markets with a lot of provider consolidation, employers are looking at innovative ways to deliver care to their employees for less money, such as on-site clinics or telehealth, explained Suzanne Delbanco, PhD, MPH, executive director of Catalyst for Payment Reform. VIDE
In markets with a lot of provider consolidation, employers are looking at innovative ways to deliver care to their employees for less money, such as on-site clinics or telehealth, explained Suzanne Delbanco, PhD, MPH, executive director of Catalyst for Payment Reform.
Transcript
How are employers responding to increased provider consolidation?
The provider landscape has been changing rapidly over the last 5, 10, even 15 years. There’s been an incredible amount of consolidation where providers come together, whether its hospital to hospital, or its healthcare systems acquiring physician groups, which is what we’re seeing now.
While its often done under the auspices of economies of scale and improving care coordination and continuity by bringing providers together, unfortunately, we don’t see any evidence that quality gets better. But, we do see mounds of evidence that prices go up as a result, so employers are very concerned about this and are starting to increasingly use benefit designs and provider network designs that will help shift their population members toward providers that offer better value overall. However, that can be very tricky to do in markets where there’s a dominant provider who puts the kibosh on doing that sort of approach.
So, it’s going to be increasingly challenging in the markets where providers are highly concentrated for employers to do innovative things like that. They are looking at on-site clinics, near-site clinics, and retail clinics expanding telehealth. All of these alternatives are less expensive sites of care, but eventually, there might be a need for government to intervene if the prices just keeping going up in the way that they are and really make healthcare unaffordable.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
Amid Debate Over Diversity, RCC Trials Still Struggle to Reflect Patient Populations
February 16th 2025Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing challenge with enrolling diverse patient populations in trials, despite stated goals.
Read More